UPDATE: Macquarie Upgrades Monsanto (MON) to Outperform
Tweet
Share
E-mailGet Alerts MON Hot Sheet
Price: $10.07 --0%
Rating Summary:
11 Buy, 13 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
11 Buy, 13 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
(Updated - June 10, 2013 10:06 AM EDT)
Macquarie upgraded Monsanto (NYSE: MON) from Neutral to Outperform with a price target of $117.00 (from $105). Analysts believe concerns about genetically modified wheat found in Oregon and potential second half weakness are overdone.
This weekend it was reported that China approved three new strains of genetically-modified (GM) soybeans and one new variety of corn for import, including Intacta, a key product for Monsanto.
For an analyst ratings summary and ratings history on Monsanto click here. For more ratings news on Monsanto click here.
Shares of Monsanto closed at $101.65 yesterday.
Macquarie upgraded Monsanto (NYSE: MON) from Neutral to Outperform with a price target of $117.00 (from $105). Analysts believe concerns about genetically modified wheat found in Oregon and potential second half weakness are overdone.
This weekend it was reported that China approved three new strains of genetically-modified (GM) soybeans and one new variety of corn for import, including Intacta, a key product for Monsanto.
For an analyst ratings summary and ratings history on Monsanto click here. For more ratings news on Monsanto click here.
Shares of Monsanto closed at $101.65 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New Street Research Upgrades Micron Technology (MU) to Buy
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Keefe, Bruyette & Woods Upgrades Nayax (NYAX) to Outperform
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Hot Upgrades, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
